Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
1h
Bristol, Merck checkpoint inhibitors focus of FDA advisory committee meeting
An FDA advisory panel on Bristol Myers Squibb Opdivo and Merck Keytruda will examine if PD-L1 tumor expression should limit ...
Oncology Nurse Advisor
9h
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
Improved disease-free survival seen among patients with high-risk muscle-invasive urothelial carcinoma after radical surgery.
The Pharma Letter
11h
Two regulatory approvals for Astellas
In a news packed morning, Japanese drugmaker Astellas Pharma (TYO: 4503) today revealed two regulatory approvals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Would-be assassin charged
Gets 2-yrs for role in fraud
Diagnosed with Parkinson's
Food packaging cancer risk
‘Trump Train’ jury verdict
Contempt charge coming?
Outlaws guitarist dies
Haitian group files complaint
Devils Tower climber dies
To shut down TikTok Music
Foreign incentives offer?
Seeks NIL compensation
Partners with Google
Russian aircraft detected
Helene forms in Caribbean
Calls for US to lift sanctions
1st NL East title since 2011
Study about oceans' acidity
EEOC blocked on rules
Recalls 41K+ motorcycles
Dali owner, operator sued
Severe obesity on the rise
Retiring after 14 seasons
DOJ sues Visa
PA county ballot ruling
Phoenix breaks heat record
Gold prices hit all-time high
OR removes 1,200+ voters
NC sending absentee ballots
Calif. school phone ban law
Related topics
KEYTRUDA
Food and Drug Administration
Merck & Co.
Feedback